From Medscape Oncology

Coverage from the

San Antonio Breast Cancer Symposium (SABCS) 2019

December 11 - 14, 2019; San Antonio, Texas

December 11 - 14, 2019 San Antonio, Texas

SABCS 2019 Paclitaxel Pill Tops IV Form, but Needs 9-Hour Fast Among women with metastatic breast cancer, use of an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form, but administration was unique and time-consuming.
Medscape Medical News, December 13, 2019
SABCS 2019 Ten-Year Results Support Partial Breast Irradiation A current phase 3 trial showed that partial breast irradiation — as opposed to irradiating the whole breast — could be a viable alternative in patients with early, low-risk breast cancer.
Medscape Medical News, December 12, 2019
SABCS 2019 Failed ATEMPT: T-DM1 No Safer in Early HER2+ Breast Cancer Trastuzumab emtansine showed no disease-free survival or safety advantage over paclitaxel + trastuzumab in the adjuvant setting for patients with stage 1 HER2-positive breast cancer.
Medscape Medical News, December 12, 2019

Meeting Highlights At A Glance

Top News From SABCS 2019: Slideshow Hot topics include a likely new standard in pretreated HER2-positive metastatic disease, a 'major' new finding in triple-negative breast cancer and 'remarkable' new data on menopausal hormone therapy.

Conference News

SABCS 2019 Anastrozole Extends Breast Cancer Protection Once Stopped
Medscape Medical News, December 18, 2019
SABCS 2019 Omit Surgery in Early-Stage Breast Cancer? Not Yet
Medscape Medical News, December 17, 2019
SABCS 2019 Novel Agent Boosts Adjuvant Therapy for High-Risk Breast Cancer
Medscape Medical News, December 16, 2019
SABCS 2019 Breast Cell Atlas Driven by Genomics
Medscape Medical News, December 16, 2019
SABCS 2019 Promising New Neoadjuvant Strategy in Luminal B Breast Cancer
Medscape Medical News, December 16, 2019
SABCS 2019 Outcomes in TN Breast Cancer Predicted by Blood Biomarkers
Medscape Medical News, December 16, 2019
SABCS 2019 Paclitaxel Pill Tops IV Form, but Needs 9-Hour Fast
Medscape Medical News, December 13, 2019
SABCS 2019 'Remarkable' New Data on Menopausal Hormone Therapy
Medscape Medical News, December 13, 2019

SABCS 2019 ImmunoRx in TNBC: Conflicting Results
Medscape Medical News, December 13, 2019
SABCS 2019 Ten-Year Results Support Partial Breast Irradiation
Medscape Medical News, December 12, 2019
SABCS 2019 Failed ATEMPT: T-DM1 No Safer in Early HER2+ Breast Cancer
Medscape Medical News, December 12, 2019
SABCS 2019 'Major Finding' in Triple-Negative Breast Cancer
Medscape Medical News, December 12, 2019
SABCS 2019 Updated APHINITY Supports Benefit of Dual HER2 Blockade
Medscape Medical News, December 11, 2019
SABCS 2019 New Standard Likely for Some Metastatic HER2 Breast Cancer
Medscape Medical News, December 11, 2019
SABCS 2019 'Compelling' Data on New Agent in Pretreated Breast Cancer
Medscape Medical News, December 11, 2019
SABCS 2019 Breast Cancer Meeting 'Is Going to Be Spectacular'
Medscape Medical News, December 3, 2019

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Oncology Insights

De-escalation of Cancer Treatment: When Is Less Really More?
Kathy D. Miller, MD; Eric P. Winer, MD
As Home Genetic Tests Flood Market, Are Physicians Being Left Behind?
Kathy D. Miller, MD; Susan Domchek, MD
Three Questions Can Help Quantify Health Disparities
Kathy D. Miller, MD; Samilia Obeng-Gyasi, MD, MPH
Early ImmunoRx Results in TNBC 'Put Us in a Difficult Position'
Kathy D. Miller, MD
'Huge Year' for HER2+ Breast Cancer: Incorporating New Treatments
Kathy D. Miller, MD; Sara A. Hurvitz, MD

Medscape Oncology Perspectives

Breakthroughs in Metastatic Breast Cancer From SABCS 2019
Harold J. Burstein, MD, PhD
Early Breast Cancer Highlights From SABCS 2019
Ann H. Partridge, MD, MPH

Popular News from SABCS 2018

Go Low With Tamoxifen for DCIS In a potentially practice-changing result, use of a 5-mg daily dose of tamoxifen for patients with ductal carcinoma in situ (DCIS) prevented new and recurrent breast cancer events in comparison with placebo.
Medscape Medical News, Dec 07, 2018
Major Trial: Partial Breast Radiation Good for Early Breast Cancer Partial breast irradiation was almost equivalant to whole-breast irradiation for disease control and can be considered a valid treatment option for women with early-stage breast cancer.
Medscape Medical News, Dec 07, 2018
Free Beer, Wine After Alcohol Warning at Cancer Meeting On opening night, an epidemiologist told meeting attendees that any alcohol intake was associated with an increased breast cancer risk. The next night, the organizers provided free beer and wine to attendees.
Medscape Medical News, Dec 07, 2018

Previous Coverage